881 related articles for article (PubMed ID: 18418308)
1. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Martin FL; Chen HH; Cataliotti A; Burnett JC
Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
4. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
5. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
8. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
Packer M
Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
[TBL] [Abstract][Full Text] [Related]
9. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
Malacco E; Limonta A; Milanesi A; Micossi P
Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
[TBL] [Abstract][Full Text] [Related]
10. Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function.
De Pasquale CG; Dunne JS; Minson RB; Arnolda LF
Eur J Heart Fail; 2005 Aug; 7(5):888-91. PubMed ID: 15916921
[TBL] [Abstract][Full Text] [Related]
11. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
12. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
Freda BJ; Slawsky M; Mallidi J; Braden GL
Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726
[TBL] [Abstract][Full Text] [Related]
13. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
De Vecchis R; Ciccarelli A; Pucciarelli A
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
[TBL] [Abstract][Full Text] [Related]
14. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
Heywood JT; Khan TA
Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
[TBL] [Abstract][Full Text] [Related]
15. The treatment targets in acute decompensated heart failure.
Fonarow GC
Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
[TBL] [Abstract][Full Text] [Related]
16. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
Weinberg MS
Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
[TBL] [Abstract][Full Text] [Related]
18. Diuretics and ultrafiltration in acute decompensated heart failure.
Felker GM; Mentz RJ
J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934
[TBL] [Abstract][Full Text] [Related]
19. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
20. [Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins].
Kahles H; Riegger AJ
Dtsch Med Wochenschr; 1987 Nov; 112(45):1737-40. PubMed ID: 3315542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
